COVER STORY: DSM-FIRMENICH
design. In a category where consumer adoption is closely tied to product feel, the ability to deliver lighter textures and more elegant finishes is critical. This is where the ingredient connects directly to consumer behaviour: better-feeling products drive more consistent use, reinforcing both brand value and public health outcomes. As Pennsylvania Congressman John Joyce,
M.D., noted: “As a board-certified dermatologist and now a physician-legislator, I understand the critical role sunscreen plays in preventing melanoma and other forms of skin cancer. “With bipartisan support, I was proud to
advance the SAFE Sunscreen Standards Act to ensure that the FDA quickly approves new sunscreen ingredients. The approval of this new sunscreen filter marks an important step forward in expanding access to innovative sun protection and helping Americans better protect themselves from harmful UV exposure.” For marketers and business leaders, the
significance of PARSOL® Shield extends well beyond formulation. Today’s sun care category is increasingly defined by premiumization, multifunctionality, and experiential value. Products must combine clinical credibility with emotional engagement—delivering not only efficacy, but also pleasure, trust, and ease of use. As Tina Vogt, Director, Global Marketing Sun
Care, explains: “Today’s consumers expect more from sunscreens — high protection, beautiful aesthetics, and textures they actually want to wear every day. PARSOL® Shield helps brands deliver all three”.
This alignment between science and
experience creates a powerful platform for differentiation. Brands can build narratives that go beyond protection—focusing on lifestyle integration, wellbeing, and long-term skin health. Carl D’Ruiz, Sr. Business Development
Manager, Beauty & Care North America, frames the opportunity clearly: “For US brands, this is more than a regulatory milestone. It is a commercial and formulation opportunity to lead with a modern UV filter that answers real consumer needs while accelerating innovation.”
Another key advantage lies in global harmonization PARSOL® Shield is already established in multiple regions, enabling more consistent formulation strategies across markets. For multinational brands, this reduces fragmentation across development pipelines and supports more efficient innovation. It can streamline processes, reduce time to market, and enable stronger cross-market consistency—critical advantages in a highly competitive category. Beyond performance, PARSOL® Shield aligns
with the growing emphasis on responsible and future-fit formulation. Its profile supports the development of more conscious sunscreen solutions, reinforcing its relevance in a market increasingly shaped by sustainability expectations. Its credibility is further supported by robust
clinical substantiation. Studies involving nearly 500 participants demonstrated high UV efficacy, excellent tolerability, and strong safety profile— key factors in building trust among regulators, brands, and consumers alike.
The broader public health dimension adds
further depth to the story. As the President of The Skin Cancer Foundation Deborah S. Sarnoff, MD, stated: “The Skin Cancer Foundation applauds the US Food and Drug Administration for approving bemotrizinol [PARSOL® Shield] for use in the American market. “Nearly 90 percent of all skin cancers are
preventable with a complete sun protection strategy, but American adoption of sun-safety practices is low. We need to do everything we can to help improve American sun protection behaviours.” Ultimately, PARSOL® Shield arrives at a
moment when the industry is asking critical questions. How can sun care deliver stronger protection without compromising aesthetics? How can products better integrate it into everyday routines? And how can brands meet rising expectations while maintaining trust and credibility?
PARSOL® Shield provides a compelling answer As Parand Salmassinia, President, Beauty & Care at dsm-firmenich, puts it: “PARSOL® Shield represents an important step forward not only for dsm-firmenich, but for the future of sun protection in the US. This milestone reflects years of scientific leadership, regulatory collaboration, and commitment to bringing meaningful innovation to consumers.” More broadly, it marks a shift in mindset. Sun
care is no longer solely about compliance or basic protection—it is about delivering products that consumers genuinely want to use, every day.
Conclusion The approval of PARSOL® Shield is a pivotal milestone—but it is also the starting point for a new phase of innovation in US sun care. For brands ready to act, the opportunity is clear: to redefine product portfolios, elevate consumer experiences, and lead a category that is finally catching up with global expectations. PARSOL® Shield is not just a new ingredient— it signals the beginning of a new era for American sun protection. Discover how you can join the sun care revolution in the US.
ADVERTISEMENT FEATURE 7
PCM
dsm-firmenich Beauty & Care
P.O.Box 2676, CH-4002 Basel, Switzerland Tel: +41 61 815 88 88 Email:
beautycare.communications@dsm-
firmenich.com Website:
www.dsm-firmenich.com
July 2026 PERSONAL CARE MAGAZINE
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72
